Cannabidiol – a potential tool for fighting SARS-CoV-2

In a new study, Fernandes, et al., aimed to determine the function of ORF8 and ORF10 genes and SARS-CoV-2 Membrane (M) protein and there effect on apoptosis...
May 30, 2022
Read

Improving Chagas disease diagnosis and treatment

Researchers from Sweden have described the variant formation of Trypanosoma cruzi which are capable of evading the immune system and causing disease...
May 27, 2022
Read

Bifonazole – a potential treatment for SARS-CoV-2 infection

In a recent paper by Taha, et al., the researchers identified the imidazole-based antifungal, Bifonazole, and characterised its activity against SARS-CoV-2 using high-throughput screening techniques...
May 25, 2022
Read

Immunodiagnostic of onchocerciasis: do we have the right tool to end the game?

In a recent study, a team from the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) collected samples of individuals living in a highly endemic focus in Central Cameroon where more than 20 years Ivermectin has been administered...
May 23, 2022
Read

Stopping inflammation in its tracks

In this recent paper, researchers were able to show the direction and degree of which the NLRP3 structure/filament expands during inflammation using cryo-electron microscopy...
May 18, 2022
Read

T cells and melanomas – a potential predictive tool

In a recent paper, Jaiswal, et al., researchers analysed several human tumour samples as well as T cell populations and tumour types in order to model T cell behaviour during cancer...
May 17, 2022
Read

COVID-19 mortality and genetic predisposition

In a new paper by Anderson, et al., the researchers established a detailed model which links COVID-19 mortality and age...
May 16, 2022
Read

Novel vaccines induce neutralising antibodies against Epstein-Barr virus in mice

Following the development of two new vaccines for the treatment of Epstein-Barr virus, a recent study by Wei, et al., have evaluated the effectiveness of these vaccines in mouse models...
May 11, 2022
Read

SARS-CoV-2 and partial resistance to remdesivir

A recent study by Stevens, et al., has demonstrated partial resistance of SARS-CoV-2 to the antiviral drug, remdesivir, in vitro.
May 10, 2022
Read

Enhancing the immune response: skin bacteria and the smallpox vaccination

A recent paper by Shmeleva, et al., the researchers have shown that vaccination for smallpox leads to an increase in skin bacteria which may enhance the immune response...
May 5, 2022
Read